CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements in the life science industry
4.1.2. Increasing number of genome projects
4.1.3. Growing incidence of infectious diseases and genetic disorders
4.1.4. Growing research activities and R&D investments in the life science industry
4.2. Market Restraints & Challenges
4.2.1. Privacy issues related to genetic information
4.2.2. Limited reimbursements for genetic testing
4.3. Market Opportunities
4.3.1. Developing countries offer significant opportunities for the market
4.3.2. Growing demand for the personalised medicine
CHAPTER 5. GLOBAL MOLECULAR BIOLOGY ENZYMES, KITS & REAGENTS
MARKET – BY PRODUCT
5.1. Introduction
5.2. Kits & reagents
5.3. Enzymes
5.3.1. Polymerases
5.3.2. Ligases
5.3.3. Restriction endonucleases
5.3.4. Reverse transcriptase
5.3.5. Phosphatases
5.3.6. Proteases and proteinases
5.3.7. Other enzymes
CHAPTER 6. GLOBAL MOLECULAR BIOLOGY ENZYMES, KITS & REAGENTS
MARKET – BY APPLICATION
6.1. Introduction
6.2. Epigenetics
6.3. Restriction digestion
6.4. Synthetic biology
6.5. Cloning
6.6. Sequencing
6.7. Polymerase chain reaction
6.8. Others
CHAPTER 7. GLOBAL MOLECULAR BIOLOGY ENZYMES KITS & REAGENTS
MARKET – BY END USER
7.1. Introduction
7.2. Hospitals & diagnostic centres
7.3. Academic & research institutes
7.4. Pharmaceutical & biotechnology companies
7.5. Other end users
CHAPTER 8. GLOBAL MOLECULAR BIOLOGY ENZYMES, KITS & REAGENTS
MARKET – BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL MOLECULAR BIOLOGY ENZYMES, KITS & REAGENTS
MARKET - COMPANY PROFILES
9.1.Molecular Biology Resources, Inc.
9.2. Jena Bioscience GmbH
9.3. Bio Basic Inc.
9.4. F. Hoffmann-La Roche Ltd
9.5. Takara Bio, Inc.
9.6. Illumina, Inc.
9.7. New England Bio labs.
9.8. Promega Corporation.
9.9. Merck KGaA.
9.10. LG Life Sciences.
9.11. Thermo Fisher Scientific, Inc.
9.12. KRISHGEN Bio Systems
9.13. Agilent Technologies, Inc.
9.14. Merck & Company, Inc.
9.15. Qiagen N.V
CHAPTER 10. GLOBAL MOLECULAR BIOLOGY ENZYMES, KITS & REAGENTS
MARKET COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
